$701.85
-6.40-0.90%
At close: -
$706.33
4.480.64%
After Hours: Dec 20, 5:12 PM EDT
Comments
Loading...
Latest news for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock
Regeneron Pharmaceuticals Stock (NASDAQ: REGN)
Categories: All
Thursday, December 19, 2024
Tuesday, December 17, 2024
- Regeneron Pharmaceuticals shares are trading ...
- Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
- Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
- What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
- Regeneron Says Primary Endpoint Was Met In Ph...
Tuesday, December 10, 2024
Monday, December 09, 2024
Sunday, December 08, 2024
Wednesday, December 04, 2024
Tuesday, December 03, 2024
Tuesday, November 26, 2024
Tuesday, November 19, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Thursday, November 14, 2024
Wednesday, November 13, 2024
Wednesday, November 06, 2024
Tuesday, November 05, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
- Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
- Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
- Regeneron shares are trading lower following ...
- Regeneron Sees FY24 Non-GAAP Gross Margin On ...
- Regeneron Pharmaceuticals Q3 2024 Adj. EPS $1...